Get started
Author

Joseph E. Rittiner

Observed names: Joseph E Rittiner, Joseph Edward Rittiner, Joseph Rittiner, Joseph E. Rittiner, Rittiner, Joseph
ORCID: 0000-0003-3592-6500
Observed ORCID: 0000-0003-3592-6500
OpenAlex ID: A5044093065
A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior
2015 · Eyal Vardy, J. Elliott Robinson, et al. · Neuron · 374
PDF
AMP Is an Adenosine A1 Receptor Agonist
2012 · Joseph E. Rittiner, Ilia Korboukh, et al. · Journal of Biological Chemistry · 125
PDF
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats
2010 · Christina L. Nemeth, Tracie A. Paine, et al. · Psychopharmacology · 104
Functional Genomic Analyses of Mendelian and Sporadic Disease Identify Impaired eIF2α Signaling as a Generalizable Mechanism for Dystonia
2016 · Joseph E. Rittiner, Zachary F. Caffall, et al. · Neuron · 86
PDF
Cholinergic neurons constitutively engage the ISR for dopamine modulation and skill learning in mice
2021 · Ashley R. Helseth, Ricardo Hernandez-Martinez, et al. · Science · 58
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
2020 · Joseph Edward Rittiner, Malik Moncalvo, et al. · Frontiers in Molecular Neuroscience · 51
PDF
The therapeutic implications of all-in-one AAV-delivered epigenome-editing platform in neurodegenerative disorders
2024 · Boris Kantor, Bernadette O’Donovan, et al. · Nature Communications · 45
PDF
Therapeutic modulation of gene expression in the disease state: Treatment strategies and approaches for the development of next-generation of the epigenetic drugs
2022 · Joseph Rittiner, Mohanapriya Cumaran, et al. · Frontiers in Bioengineering and Biotechnology · 40
PDF
Orally Active Adenosine A1Receptor Agonists with Antinociceptive Effects in Mice
2012 · Ilia Korboukh, Emily A. Hull-Ryde, et al. · Journal of Medicinal Chemistry · 26
The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia
2021 · Zachary F. Caffall, Bradley J. Wilkes, et al. · Science Translational Medicine · 22
Overexpression of Diacylglycerol Kinase η Enhances Gαq-Coupled G Protein–Coupled Receptor Signaling
2014 · Joseph E. Rittiner, Victoria E. Brings, et al. · Molecular Pharmacology · 14
PDF
Biological constraints limit the use of rapamycin-inducible FKBP12-Inp54p for depleting PIP2 in dorsal root ganglia neurons
2013 · Jaeda C Coutinho-Budd, Samuel B Snider, et al. · Journal of Negative Results in BioMedicine · 11
PDF
APOE‐targeted epigenome therapy for late onset Alzheimer’s disease
2022 · Boris Kantor, Joseph Rittiner, et al. · Alzheimer s & Dementia · 5
APOE‐targeted epigenome therapy for late onset Alzheimer’s disease
2023 · Boris Kantor, Joseph Rittiner, et al. · Alzheimer s & Dementia · 1
PDF
Allele specific targeting of APOE‐E4 expression: The novel CRISRP/CAS9‐based platform for precision therapy for Alzheimer’s disease
2020 · Boris Kantor, Malik Moncalvo, et al. · Alzheimer s & Dementia · 1
PDF
SNCA-targeted transcriptional repression therapy alleviates pathological and behavioral perturbations in a Parkinson's disease mouse model
2026 · Bernadette O'Donovan, Joseph Rittiner, et al. · Neurotherapeutics
Extracellular and Intracellular Regulation of G Protein-Coupled Receptor Signaling
2019 · Rittiner, Joseph · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Works count: 17
Citation count: 963
H-index: 11
I10-index: 12
Year
Topic
Type